Please login to the form below

Not currently logged in

CanSino Biologics

This page shows the latest CanSino Biologics news and features for those working in and with pharma, biotech and healthcare.

CanSinoBIO considers booster jab for COVID-19 vaccine

CanSinoBIO considers booster jab for COVID-19 vaccine

The efficacy of Chinese biotech company CanSino Biologics's (CanSinoBio) single-dose COVID-19 vaccine could decrease over time, according to the company’s chief scientific officer Zhu Tao.

Latest news

More from news
Approximately 2 fully matching, plus 2 partially matching documents found.

Latest Intelligence

  • Developing a COVID-19 vaccine Developing a COVID-19 vaccine

    The volunteers will be isolated for 14 days after being dosed with the adenovirus-based Ad5-nCoV shot, which was developed in collaboration with CanSino Biologics, and will then be monitored

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs


Add my company

Hamell is a full-service agency with a clear focus on delivering evidence-based, sustained behaviour change. So, whether you are looking...

Latest intelligence

DATA shutterstock_1818502577-640.jpg
Empowering patients empowers results
Patient-centricity is key when it comes to creating a more flexible, efficient and modern process for clinical trials...
Don’t limit diversity to just representation in clinical trials
What is the power of diversity in the healthcare environment? Can it make clinical trials more inclusive?...
Oh no… not more training
Paul Hutchings, founder of fox&cat, discusses ways to help your team manage pressure in a more human, pressure-centric and engaging way...